Abbott (NYSE:ABT) has agreed to pay $160 million to resolve False Claims Act violation allegations it inherited from Alere, which it acquired in 2017. The settlement resolves allegations that Alere’s Arriva Medical — a mail-order diabetic testing supply company that ceased operations in December 2017 — paid kickbacks to Medicare beneficiaries, patients who were ineligible […]